Kennedy's autism plan overlooks scientific evidence. Only population-wide, longitudinal studies can reveal the complex roots of autism. Simpler approaches lead to dead ends.

Rare disease research is vital to improve ... By minimising the exposure to ineffective therapies, RAR trial designs improve recruitment and retention rates, and are an efficient use of limited ...

A US teenager was recently reported to have developed the oddly named medical condition “popcorn lung” after vaping in secret ...

Interim data from ENERGY 3 trial highlight INZ-701's potential to modify disease course in ENPP1 Deficiency, with sustained ...

In a first-of-its-kind clinical study, scientists at the University of Texas at Dallas and Baylor University Medical Center have shown that patients with treatment-resistant PTSD were symptom-free up ...

Here’s the truth: Most dashboards are dense, nuanced, and missing the context or causality needed to drive strategic change.

In a Phase 2a study in patients with MELAS, zagociguat exhibited a favorable safety profile, exposure throughout the body including in the central nervous system, and improvements in neuronal function ...

Inhibikase (IKT) pivots to IkT-001Pro for PAH amid competition like Merck’s sotatercept. Backed by $97.5M, results will ...

In the modern business environment, ERP transformations are not just technology refreshes—they're business-critical ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

Despite its impressive performance, ChatGPT exhibited systematic deviations in specific areas. It showed difficulty ...